
Jubilant Pharmova Ltd
NSE: JUBLPHARMA BSE: 530019
₹985
(2.85)%
Tue, 03 Feb 2026, 08:37 am
Market Cap156.22B
PE Ratio32.75
Dividend0.51
Financials
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 14.75B | 18.10B | 24.89B | 35.18B | 37.81B | 34.33B | 42.21B | 51.09B | 57.22B | 57.76B | 56.92B | 57.96B | 74.56B | 90.27B | 59.76B | 60.99B | 61.30B | 62.64B | 66.96B | 72.27B |
| Gross profit | 1.92B | 4.60B | 6.87B | 9.58B | 9.43B | 7.39B | 9.66B | 11.72B | 11.30B | 9.39B | 13.18B | 15.13B | 18.10B | 22.20B | 19.40B | 17.73B | 15.68B | 9.81B | 13.64B | 16.50B |
| Operating expenses (excl. COGS) | -295.58M | -2.63B | -3.30B | -4.48B | -4.03B | -3.69B | -3.52B | -3.80B | -4.70B | -5.74B | -4.01B | -5.08B | -6.81B | -8.81B | -6.90B | -6.63B | -7.42B | -7.74B | -8.50B | -9.77B |
| Selling/general/admin expenses, total | -101.78M | -2.55B | -3.18B | -4.27B | -3.80B | -3.39B | -3.23B | -3.47B | -4.27B | -5.25B | -3.93B | -4.63B | -6.26B | -8.09B | -6.24B | -5.90B | -6.67B | -6.87B | -7.45B | -7.47B |
| Research & development | -101.78M | -130.50M | -228.40M | -332.34M | -408.47M | -402.38M | -345.69M | -446.98M | -538.87M | -251.47M | -131.16M | -161.64M | -182.05M | — | — | — | — | — | -148.00M | -120.00M |
| Selling/general/admin expenses, other | — | -2.42B | -2.95B | -3.93B | -3.39B | -2.99B | -2.88B | -3.02B | -3.73B | -5.00B | -3.80B | -4.47B | -6.08B | -8.09B | -6.24B | -5.90B | -6.67B | -6.87B | -7.30B | -7.35B |
| Other operating expenses, total | -193.80M | -79.33M | -127.71M | -209.68M | -226.43M | -300.24M | -293.40M | -331.17M | -427.16M | -489.42M | -80.43M | -447.87M | -551.32M | -723.97M | -661.38M | -723.16M | -755.77M | -868.23M | -1.05B | -2.30B |
| Operating income | 1.73B | 1.96B | 3.56B | 5.10B | 5.41B | 3.69B | 6.14B | 7.92B | 6.60B | 3.65B | 9.17B | 10.05B | 11.30B | 13.38B | 12.50B | 11.10B | 8.25B | 2.07B | 5.14B | 6.74B |
| Non-operating income, total | -68.89M | 964.92M | 966.01M | -2.17B | -230.69M | -1.28B | -5.00B | -4.51B | -4.52B | -3.24B | -3.96B | -2.67B | -2.70B | -4.35B | -2.37B | -2.50B | -1.85B | -1.91B | -3.68B | 3.07B |
| Interest expense, net of interest capitalized | -180.94M | -219.55M | -350.80M | -1.12B | -1.56B | -1.11B | -2.26B | -2.41B | -3.37B | -3.68B | -3.71B | -3.40B | -2.83B | -2.19B | -2.00B | -1.84B | -1.45B | -1.88B | -2.72B | -2.40B |
| Interest capitalized | 0 | 0 | 209.97M | 241.06M | 102.82M | 220.59M | 257.40M | 227.57M | 81.45M | 171.50M | 360.59M | 449.33M | 153.21M | 0 | 154.37M | 101.64M | 31.09M | 92.90M | 94.00M | 131.00M |
| Non-operating income, excl. interest expenses | 115.45M | 1.19B | 1.32B | -1.64B | 1.33B | -57.58M | 746.24M | 275.51M | 1.13B | 274.79M | -30.75M | 771.14M | 1.04B | 642.29M | -47.45M | -450.22M | -393.31M | 536.26M | 732.00M | 7.42B |
| Non-operating interest income | 55.30M | 450.18M | 267.03M | 75.04M | 50.54M | 62.44M | 161.95M | 113.05M | 52.20M | 62.40M | 27.39M | 87.79M | 51.30M | 109.68M | 189.46M | 80.97M | 24.51M | 98.28M | 261.00M | 366.00M |
| Miscellaneous non-operating expense | 60.15M | 736.76M | 1.05B | -1.71B | 1.28B | -120.02M | 584.29M | 162.46M | 1.08B | 212.39M | -58.14M | 683.35M | 988.96M | -305.60M | -236.91M | -531.19M | -417.82M | 258.66M | 399.00M | 6.97B |
| Unusual income/expense | -3.40M | -2.47M | -2.79M | 587.89M | -4.04M | -113.80M | -3.49B | -2.37B | -2.29B | 158.69M | -212.27M | -36.90M | -910.22M | -2.80B | -329.34M | -212.31M | 0 | -568.16M | -1.69B | -1.94B |
| Pretax income | 1.66B | 2.93B | 4.53B | 2.94B | 5.18B | 2.41B | 1.14B | 3.41B | 2.07B | 403.24M | 5.42B | 7.38B | 8.59B | 9.04B | 10.13B | 8.60B | 6.40B | 155.29M | 1.46B | 9.81B |
| Taxes | -370.09M | -688.45M | -545.18M | -238.86M | -959.44M | -133.65M | -684.14M | -1.52B | -696.44M | -804.84M | -1.55B | -1.63B | -2.25B | -3.27B | -3.35B | -2.97B | -2.17B | -926.62M | -978.00M | -1.44B |
| Non-controlling/minority interest | 7.80M | 39.45M | 16.47M | 133.19M | -4.92M | 24.93M | -311.32M | -360.51M | -285.99M | -176.04M | 50.08M | 10.27M | 83.88M | -25.52M | 30.00K | 2.58M | 9.20M | 39.01M | 44.00M | 31.00M |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 1.30B | 2.28B | 4.00B | 2.83B | 4.21B | 2.30B | 145.61M | 1.53B | 1.09B | -577.64M | 3.92B | 5.76B | 6.43B | 5.74B | 6.78B | 5.74B | 4.14B | -609.80M | 771.00M | 8.39B |
| Net income | 1.30B | 2.28B | 4.00B | 2.83B | 4.21B | 2.30B | 145.61M | 1.53B | 1.09B | -577.64M | 3.92B | 5.76B | 6.43B | 5.74B | 8.98B | 8.36B | 4.14B | -609.80M | 771.00M | 8.39B |
| Dilution adjustment | 0 | 0 | 280.00K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 1.30B | 2.28B | 4.01B | 2.83B | 4.21B | 2.30B | 145.61M | 1.53B | 1.09B | -577.64M | 3.92B | 5.76B | 6.43B | 5.74B | 8.98B | 8.36B | 4.14B | -609.80M | 771.00M | 8.39B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 2.16B | 2.62B | 4.63B | 6.75B | 6.66B | 5.49B | 8.35B | 10.46B | 9.41B | 6.53B | 12.63B | 12.92B | 14.54B | 17.09B | 15.90B | 14.59B | 12.07B | 7.61B | 8.96B | 10.42B |
| EBIT | 1.63B | 1.96B | 3.56B | 5.10B | 5.41B | 3.69B | 6.14B | 7.92B | 6.60B | 3.65B | 9.17B | 10.05B | 11.30B | 13.38B | 12.50B | 11.10B | 8.25B | 2.07B | 5.14B | 6.74B |
| Total operating expenses | -13.02B | -16.13B | -21.32B | -30.08B | -32.41B | -30.64B | -36.06B | -43.17B | -50.62B | -54.12B | -47.75B | -47.91B | -63.26B | -76.89B | -47.26B | -49.88B | -53.05B | -60.57B | -61.81B | -65.53B |
| Prepaid expenses | 576.24M | 896.10M | 654.30M | 403.47M | 653.91M | 764.72M | 674.97M | 961.09M | — | 553.21M | 325.81M | 377.70M | 559.55M | 685.01M | 741.59M | 823.74M | 833.54M | 899.80M | 910.00M | 1.05B |
| Deferred income, current | — | — | — | — | — | — | 570.26M | 477.88M | 598.16M | 616.97M | 469.70M | 464.44M | 476.35M | 400.21M | 624.65M | 536.83M | 902.04M | 710.73M | 865.00M | 1.23B |
| Capital and operating lease obligations | 1.23M | 1.23M | 800.00K | 140.00K | 50.00K | 0 | 29.05M | 26.06M | 15.00M | 14.51M | 38.81M | 73.42M | 73.42M | 110.87M | 1.95B | 1.95B | 2.12B | 2.13B | 1.98B | 2.38B |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 1.12B | 1.42B | 1.55B | 2.32B | 2.81B | 2.11B | 2.24B | 3.24B | 2.37B | 6.26B | 1.99B | 1.86B | 1.63B | 2.02B | 2.63B | 2.47B | 3.03B | 3.06B | 2.11B | 1.72B |
| Deferred income, non-current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 104.06M | 82.10M | 123.57M | 96.94M | 77.59M | 44.75M | 25.22M | 27.89M | 30.48M | 26.12M | 22.00M | 12.00M |
| Minority interest | 150.89M | 174.12M | 213.91M | 319.52M | 379.18M | 418.11M | 689.52M | 1.12B | 1.58B | 0 | -381.33M | -473.88M | -515.22M | 990.00K | 0 | 310.00K | -21.63M | -74.89M | -128.00M | -163.00M |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | -189.43M | -202.82M | -208.72M | -257.62M | -257.53M | -369.12M | -368.08M | -548.30M | -552.36M | -538.05M | -555.42M | -558.65M | -560.30M | -545.86M | -1.53B | -14.75M | -800.53M | -800.61M | -798.00M | -796.00M |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800